Perrigo Company PLC Plans Quarterly Dividend of $0.11 (PRGO)
Perrigo Company PLC (NASDAQ:PRGO) announced a quarterly dividend on Wednesday, August 13th, Analyst Ratings News reports. Stockholders of record on Friday, August 29th will be paid a dividend of 0.105 per share on Tuesday, September 16th. This represents a $0.42 annualized dividend and a dividend yield of 0.30%.
A number of analysts have recently weighed in on PRGO shares. Analysts at Deutsche Bank initiated coverage on shares of Perrigo Company PLC in a research note on Tuesday, July 22nd. They set a “buy” rating and a $189.00 price target on the stock. On the ratings front, analysts at Morgan Stanley downgraded shares of Perrigo Company PLC from an “overweight” rating to an “equal weight” rating in a research note on Friday, July 11th. Finally, analysts at Argus cut their price target on shares of Perrigo Company PLC from $175.00 to $160.00 in a research note on Thursday, May 15th. They now have a “buy” rating on the stock. Three research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $166.25.
Perrigo Company PLC (NASDAQ:PRGO) traded up 0.11% during mid-day trading on Wednesday, hitting $139.15. The stock had a trading volume of 1,897,027 shares. Perrigo Company PLC has a 1-year low of $115.94 and a 1-year high of $168.39. The stock’s 50-day moving average is $150.1 and its 200-day moving average is $149.0. The company has a market cap of $18.618 billion and a P/E ratio of 76.29.
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.